Corbus Pharmaceuticals Holdings, Inc. (CRBP) DCF Valuation

Corbus Pharmaceuticals Holdings, Inc. (CRBP) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial prospects of Corbus Pharmaceuticals Holdings, Inc. (CRBP) with our easy-to-use DCF Calculator! Enter your assumptions for growth, margins, and costs to calculate the intrinsic value of Corbus Pharmaceuticals Holdings, Inc. (CRBP) and enhance your investment strategy.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 36.1 3.9 .9 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -89.11 -77.61 -100 0 -66.68 -66.68 -66.68 -66.68 -66.68
EBITDA -76.4 -121.7 -55.0 -38.7 -44.4 .0 .0 .0 .0 .0
EBITDA, % -211.28 -3090.65 -6234.59 100 100 -20 -20 -20 -20 -20
Depreciation 1.2 1.7 1.6 1.5 .6 .0 .0 .0 .0 .0
Depreciation, % 3.4 43.03 185.92 100 100 69.29 69.29 69.29 69.29 69.29
EBIT -77.6 -123.4 -56.6 -40.2 -45.1 .0 .0 .0 .0 .0
EBIT, % -214.69 -3133.68 -6420.51 100 100 -20 -20 -20 -20 -20
Total Cash 31.7 85.4 97.6 59.2 20.9 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 2.7 2.6 .0 .0 .0
Account Receivables, % 7.42 65.49 0 100 100
Inventories -2.7 .4 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % -7.42 8.89 0 100 100 40.29 40.29 40.29 40.29 40.29
Accounts Payable 11.1 7.4 1.8 2.2 3.2 .0 .0 .0 .0 .0
Accounts Payable, % 30.69 187.47 202.14 100 100 86.14 86.14 86.14 86.14 86.14
Capital Expenditure -2.7 -.5 -.1 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -7.59 -12.31 -6.14 100 100 -5.21 -5.21 -5.21 -5.21 -5.21
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -75.1 -123.4 -56.5 -53.0 -45.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -65.5 -128.8 -57.6 -51.2 -43.4 -3.2 .0 .0 .0 .0
WACC, % 15.73 15.86 15.85 15.86 15.86 15.83 15.83 15.83 15.83 15.83
PV UFCF
SUM PV UFCF -2.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -3
Net Debt 7
Equity Value -10
Diluted Shares Outstanding, MM 4
Equity Value Per Share -2.29

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real CRBP financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on Corbus Pharmaceuticals’ valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive Data: Access to Corbus Pharmaceuticals' historical financial statements and pre-filled projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: Monitor the intrinsic value of Corbus Pharmaceuticals recalculating instantly.
  • Intuitive Visual Outputs: Dashboard charts illustrate valuation results and essential metrics clearly.
  • Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Corbus Pharmaceuticals data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Corbus Pharmaceuticals' intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Corbus Pharmaceuticals (CRBP)?

  • Comprehensive Tool: Incorporates DCF, WACC, and financial ratio analyses tailored for Corbus Pharmaceuticals.
  • Customizable Inputs: Modify yellow-highlighted cells to explore various financial scenarios for (CRBP).
  • Detailed Insights: Automatically computes Corbus Pharmaceuticals' intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable starting points for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on (CRBP).

Who Should Use Corbus Pharmaceuticals Holdings, Inc. (CRBP)?

  • Pharmaceutical Students: Explore drug development processes and apply them using real-world data.
  • Researchers: Integrate innovative models into your studies or clinical research.
  • Investors: Evaluate your investment strategies and analyze valuation trends for Corbus Pharmaceuticals.
  • Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech firms.
  • Healthcare Entrepreneurs: Understand how public biotech companies like Corbus are assessed and valued.

What the Template Contains

  • Preloaded CRBP Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

Es wurden keine passenden Produkte gefunden.